ID   KCNC2_RAT               Reviewed;         638 AA.
AC   P22462; P22461; P22463; Q63735;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1991, sequence version 1.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Voltage-gated potassium channel KCNC2 {ECO:0000305};
DE   AltName: Full=Potassium channel voltage-gated Shaw-related subfamily C member 2 {ECO:0000312|RGD:628829};
DE   AltName: Full=Potassium voltage-gated channel subfamily C member 2 {ECO:0000312|RGD:628829};
DE   AltName: Full=Shaw-like potassium channel {ECO:0000303|PubMed:1879548};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.2 {ECO:0000303|PubMed:1879548};
GN   Name=Kcnc2 {ECO:0000312|RGD:628829};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, TRANSPORTER ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY REGULATION.
RC   TISSUE=Brain;
RX   PubMed=2367536; DOI=10.1073/pnas.87.13.5227;
RA   McCormack T., de Miera E.C.V.-S., Rudy B.;
RT   "Molecular cloning of a member of a third class of Shaker-family K+ channel
RT   genes in mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:5227-5231(1990).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=2023956; DOI=10.1073/pnas.88.9.4060-b;
RA   McCormack T., de Miera E.C.V.-S., Rudy B.;
RT   "Molecular cloning of a member of a third class of Shaker-family K+ channel
RT   genes in mammals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:4060-4060(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TRANSPORTER
RP   ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=1879548; DOI=10.1016/0014-5793(91)81026-5;
RA   Luneau C.J., Wiedmann R., Smith J.S., Williams J.B.;
RT   "Shaw-like rat brain potassium channel cDNA's with divergent 3' ends.";
RL   FEBS Lett. 288:163-167(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=1378392; DOI=10.1002/j.1460-2075.1992.tb05312.x;
RA   Rettig J., Wunder F., Stocker M., Lichtinghagen R., Mastiaux F., Beckh S.,
RA   Kues W., Pedarzani P., Schroeter K.H., Ruppersberg J.P., Veh R., Pongs O.;
RT   "Characterization of a Shaw-related potassium channel family in rat
RT   brain.";
RL   EMBO J. 11:2473-2486(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=1374908; DOI=10.1073/pnas.89.10.4603;
RA   Baker H., Pollock J., Ellisman M., Kentros C., Miera E., Serodio P.,
RA   Weiser M., Rudy B., Fruhling D.;
RT   "Region-specific expression of a K+ channel gene in brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4603-4607(1992).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8120636; DOI=10.1523/jneurosci.14-03-00949.1994;
RA   Weiser M., Vega-Saenz de Miera E., Kentros C., Moreno H., Franzen L.,
RA   Hillman D., Baker H., Rudy B.;
RT   "Differential expression of Shaw-related K+ channels in the rat central
RT   nervous system.";
RL   J. Neurosci. 14:949-972(1994).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, PHOSPHORYLATION, MUTAGENESIS OF SER-563 AND SER-564,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=7643197; DOI=10.1523/jneurosci.15-08-05486.1995;
RA   Moreno H., Kentros C., Bueno E., Weiser M., Hernandez A.,
RA   Vega-Saenz de Miera E., Ponce A., Thornhill W., Rudy B.;
RT   "Thalamocortical projections have a K+ channel that is phosphorylated and
RT   modulated by cAMP-dependent protein kinase.";
RL   J. Neurosci. 15:5486-5501(1995).
RN   [8]
RP   SUBCELLULAR LOCATION (ISOFORMS 1; 2 AND 3).
RX   PubMed=9307441; DOI=10.1007/s002329900278;
RA   Ponce A., Vega-Saenz de Miera E., Kentros C., Moreno H., Thornhill B.,
RA   Rudy B.;
RT   "K+ channel subunit isoforms with divergent carboxy-terminal sequences
RT   carry distinct membrane targeting signals.";
RL   J. Membr. Biol. 159:149-159(1997).
RN   [9]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY
RP   REGULATION, SUBUNIT, INTERACTION WITH KCNC1, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=10482766; DOI=10.1152/jn.1999.82.3.1512;
RA   Hernandez-Pineda R., Chow A., Amarillo Y., Moreno H., Saganich M.,
RA   Vega-Saenz de Miera E.C., Hernandez-Cruz A., Rudy B.;
RT   "Kv3.1-Kv3.2 channels underlie a high-voltage-activating component of the
RT   delayed rectifier K+ current in projecting neurons from the globus
RT   pallidus.";
RL   J. Neurophysiol. 82:1512-1528(1999).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10414968; DOI=10.1523/jneurosci.19-15-06394.1999;
RA   Baranauskas G., Tkatch T., Surmeier D.J.;
RT   "Delayed rectifier currents in rat globus pallidus neurons are attributable
RT   to Kv2.1 and Kv3.1/3.2 K(+) channels.";
RL   J. Neurosci. 19:6394-6404(1999).
RN   [11]
RP   REVIEW.
RX   PubMed=10414303; DOI=10.1111/j.1749-6632.1999.tb11295.x;
RA   Rudy B., Chow A., Lau D., Amarillo Y., Ozaita A., Saganich M., Moreno H.,
RA   Nadal M.S., Hernandez-Pineda R., Hernandez-Cruz A., Erisir A., Leonard C.,
RA   Vega-Saenz de Miera E.;
RT   "Contributions of Kv3 channels to neuronal excitability.";
RL   Ann. N. Y. Acad. Sci. 868:304-343(1999).
RN   [12]
RP   REVIEW.
RX   PubMed=11506885; DOI=10.1016/s0166-2236(00)01892-0;
RA   Rudy B., McBain C.J.;
RT   "Kv3 channels: voltage-gated K+ channels designed for high-frequency
RT   repetitive firing.";
RL   Trends Neurosci. 24:517-526(2001).
RN   [13]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF SER-563 AND SER-564.
RX   PubMed=11281123; DOI=10.1111/j.1469-7793.2001.0345k.x;
RA   Moreno H., Vega-Saenz de Miera E., Nadal M.S., Amarillo Y., Rudy B.;
RT   "Modulation of Kv3 potassium channels expressed in CHO cells by a nitric
RT   oxide-activated phosphatase.";
RL   J. Physiol. (Lond.) 530:345-358(2001).
RN   [14]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT,
RP   INTERACTION WITH KCNC1; KCNE1; KCNE2 AND KCNE3, AND SUBCELLULAR LOCATION.
RX   PubMed=14679187; DOI=10.1074/jbc.m310501200;
RA   Lewis A., McCrossan Z.A., Abbott G.W.;
RT   "MinK, MiRP1, and MiRP2 diversify Kv3.1 and Kv3.2 potassium channel
RT   gating.";
RL   J. Biol. Chem. 279:7884-7892(2004).
RN   [15]
RP   TISSUE SPECIFICITY.
RX   PubMed=16413129; DOI=10.1016/j.neuroscience.2005.11.047;
RA   McDonald A.J., Mascagni F.;
RT   "Differential expression of Kv3.1b and Kv3.2 potassium channel subunits in
RT   interneurons of the basolateral amygdala.";
RL   Neuroscience 138:537-547(2006).
RN   [16]
RP   INDUCTION.
RX   PubMed=18775767; DOI=10.1016/j.neuroscience.2008.08.008;
RA   Grabert J., Wahle P.;
RT   "Neuronal activity and TrkB ligands influence Kv3.1b and Kv3.2 expression
RT   in developing cortical interneurons.";
RL   Neuroscience 156:618-629(2008).
RN   [17]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=18708127; DOI=10.1016/j.neuroscience.2008.07.035;
RA   Grabert J., Wahle P.;
RT   "Visual experience regulates Kv3.1b and Kv3.2 expression in developing rat
RT   visual cortex.";
RL   Neuroscience 158:654-664(2009).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=22831914; DOI=10.1016/j.ceca.2012.06.007;
RA   Kuznetsov K.I., Grygorov O.O., Maslov V.Y., Veselovsky N.S., Fedulova S.A.;
RT   "Kv3 channels modulate calcium signals induced by fast firing patterns in
RT   the rat retinal ganglion cells.";
RL   Cell Calcium 52:405-411(2012).
CC   -!- FUNCTION: Voltage-gated potassium channel that mediates transmembrane
CC       potassium transport in excitable membranes, primarily in the brain.
CC       Contributes to the regulation of the fast action potential
CC       repolarization and in sustained high-frequency firing in neurons of the
CC       central nervous system (PubMed:10414968, PubMed:10482766,
CC       PubMed:11506885, PubMed:22831914). Homotetramer channels mediate
CC       delayed-rectifier voltage-dependent potassium currents that activate
CC       rapidly at high-threshold voltages and inactivate slowly
CC       (PubMed:10414303, PubMed:10482766, PubMed:11281123, PubMed:14679187,
CC       PubMed:1879548, PubMed:2367536, PubMed:7643197, PubMed:8120636). Forms
CC       tetrameric channels through which potassium ions pass in accordance
CC       with their electrochemical gradient. The channel alternates between
CC       opened and closed conformations in response to the voltage difference
CC       across the membrane (PubMed:1879548, PubMed:2367536, PubMed:7643197,
CC       PubMed:8120636). Can form functional homotetrameric channels and
CC       heterotetrameric channels that contain variable proportions of KCNC1,
CC       and possibly other family members as well; channel properties depend on
CC       the type of alpha subunits that are part of the channel
CC       (PubMed:10482766, PubMed:14679187). Channel properties may be modulated
CC       either by the association with ancillary subunits, such as KCNE1, KCNE2
CC       and KCNE3 or indirectly by nitric oxide (NO) through a cGMP- and PKG-
CC       mediated signaling cascade, slowing channel activation and deactivation
CC       of delayed rectifier potassium channels (PubMed:11281123,
CC       PubMed:14679187). Contributes to fire sustained trains of very brief
CC       action potentials at high frequency in retinal ganglion cells,
CC       thalamocortical and suprachiasmatic nucleus (SCN) neurons and in
CC       hippocampal and neocortical interneurons (PubMed:10414968,
CC       PubMed:10482766, PubMed:11506885, PubMed:22831914). Sustained maximal
CC       action potential firing frequency in inhibitory hippocampal
CC       interneurons is negatively modulated by histamine H2 receptor
CC       activation in a cAMP- and protein kinase (PKA) phosphorylation-
CC       dependent manner. Plays a role in maintaining the fidelity of synaptic
CC       transmission in neocortical GABAergic interneurons by generating action
CC       potential (AP) repolarization at nerve terminals, thus reducing spike-
CC       evoked calcium influx and GABA neurotransmitter release. Required for
CC       long-range synchronization of gamma oscillations over distance in the
CC       neocortex. Contributes to the modulation of the circadian rhythm of
CC       spontaneous action potential firing in suprachiasmatic nucleus (SCN)
CC       neurons in a light-dependent manner (By similarity).
CC       {ECO:0000250|UniProtKB:Q14B80, ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:11281123,
CC       ECO:0000269|PubMed:11506885, ECO:0000269|PubMed:14679187,
CC       ECO:0000269|PubMed:1879548, ECO:0000269|PubMed:22831914,
CC       ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC       ECO:0000269|PubMed:8120636, ECO:0000305|PubMed:10414303,
CC       ECO:0000305|PubMed:11506885}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:11281123,
CC         ECO:0000269|PubMed:14679187, ECO:0000269|PubMed:1879548,
CC         ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC         ECO:0000269|PubMed:8120636};
CC   -!- ACTIVITY REGULATION: Inhibited by Stichodactyla helianthus peptide ShK
CC       (By similarity). Inhibited by millimolar levels of tetraethylammonium
CC       (TEA). Contrary to other channels, inhibited only by millimolar levels
CC       of 4-aminopyridine (4-AP) (PubMed:10414303, PubMed:10482766,
CC       PubMed:1879548, PubMed:2367536, PubMed:7643197).
CC       {ECO:0000250|UniProtKB:Q96PR1, ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:1879548, ECO:0000269|PubMed:2367536,
CC       ECO:0000269|PubMed:7643197, ECO:0000305|PubMed:10414303}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=Homotetrameric channels expressed in xenopus oocytes or in
CC         mammalian non-neuronal cells display delayed-rectifier voltage-
CC         dependent potassium currents, that are rapidly activated during
CC         membrane depolarization, i.e within a risetime of a few msec. After
CC         that, inactivates very slowly, i.e within about >800 msec. Their
CC         activation requires a threshold potential at about -10 mV, with a
CC         midpoint activation at about 12.1 mV and a steepness parameter of
CC         about 8.4 mV (PubMed:10414303, PubMed:11281123, PubMed:14679187,
CC         PubMed:1879548, PubMed:2367536, PubMed:7643197, PubMed:8120636). The
CC         voltage-dependence of activation and inactivation and other channel
CC         characteristics vary depending on the experimental conditions, the
CC         expression system, the presence or absence of ancillary subunits and
CC         post-translational modifications (PubMed:10414303, PubMed:11281123,
CC         PubMed:14679187, PubMed:7643197). {ECO:0000269|PubMed:11281123,
CC         ECO:0000269|PubMed:14679187, ECO:0000269|PubMed:1879548,
CC         ECO:0000269|PubMed:2367536, ECO:0000269|PubMed:7643197,
CC         ECO:0000269|PubMed:8120636, ECO:0000305|PubMed:10414303};
CC   -!- SUBUNIT: Homotetramer and heterotetramer with other channel-forming
CC       alpha subunits, such as KCNC1. Interacts with KCNC1 (PubMed:10482766,
CC       PubMed:14679187). Homotetramer or heterotetramer channel activity is
CC       regulated by association with modulating ancillary subunits such as
CC       KCNE1, KCNE2 and KCNE3, creating a functionally diverse range of
CC       channel complexes. Interacts with KCNE1, KCNE2 and KCNE3
CC       (PubMed:14679187). {ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:14679187}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:14679187,
CC       ECO:0000269|PubMed:22831914, ECO:0000269|PubMed:7643197}; Multi-pass
CC       membrane protein {ECO:0000255}. Membrane {ECO:0000269|PubMed:11281123};
CC       Multi-pass membrane protein {ECO:0000255}. Perikaryon
CC       {ECO:0000269|PubMed:10482766}. Cell projection, axon
CC       {ECO:0000269|PubMed:7643197}. Synapse {ECO:0000269|PubMed:7643197}.
CC       Synapse, synaptosome {ECO:0000269|PubMed:7643197}. Cell projection,
CC       dendrite {ECO:0000250|UniProtKB:Q14B80}. Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q14B80}. Presynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q14B80}. Note=Localizes on the surface of cell
CC       somata, proximal dendrites and axonal membranes. Also detected
CC       throughout the neuropil. Localized in starburst cell somata and
CC       proximal dendrite processes. Colocalized with GABA in presynaptic
CC       terminals. Clustered in patches in somatic and proximal dendritic
CC       membrane as well as in axons and presnypatic terminals of GABAergic
CC       interneurons; some of these patches are found near postsynaptic sites
CC       (By similarity). Colocalizes with parvalbumin in globus pallidus
CC       neurons (PubMed:10482766). Localizes in thalamocortical axons and
CC       synapses (PubMed:7643197). {ECO:0000250|UniProtKB:Q14B80,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:7643197}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Apical cell membrane
CC       {ECO:0000269|PubMed:9307441}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Apical cell membrane
CC       {ECO:0000269|PubMed:9307441}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Basolateral cell membrane
CC       {ECO:0000269|PubMed:9307441}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=KV3.2B {ECO:0000303|PubMed:1879548};
CC         IsoId=P22462-1; Sequence=Displayed;
CC       Name=2; Synonyms=KV3.2C {ECO:0000303|PubMed:1879548};
CC         IsoId=P22462-2; Sequence=VSP_001018;
CC       Name=3; Synonyms=KV3.2A, KShIIIA.1 {ECO:0000303|PubMed:2367536};
CC         IsoId=P22462-3; Sequence=VSP_001019;
CC       Name=4;
CC         IsoId=P22462-4; Sequence=VSP_001020;
CC   -!- TISSUE SPECIFICITY: Expressed in neurons of the visual cortex during
CC       postnatal development (PubMed:18708127). Expressed in neurons of the
CC       globus pallidus at postnatal age day 7 (P7), onward (PubMed:10482766).
CC       Expressed in thalamic relay neurons. Expressed in neurons in layer IV
CC       and deeper cortical layers of the neocortex. Expressed in hippocampal
CC       interneurons (PubMed:7643197). Expressed in nonpyramidal interneurons
CC       in the basolateral amygdala (PubMed:16413129). Expressed in retinal
CC       ganglion cells (at protein level) (PubMed:22831914). Widely expressed
CC       in the brain (PubMed:1879548, PubMed:8120636). Expressed in numerous
CC       thalamic relay neurons throughout the dorsal thalamus. Expressed in
CC       interneurons of the deep layers V-VI of the cerebral cortex, the CA1
CC       and CA3 pyramidal and dentate gyrus (DG) granule cells of the
CC       hippocampus, in neurons of the caudate-putamen, globus pallidus and
CC       subthalamic nucleus. Also expressed in the optic layer of interior
CC       colliculus, the inferior colliculus, the red nucleus, the medial
CC       geniculate, the ventral lateral lemiscus, the reticulotegmental nucleus
CC       and in the deep cerebellar nuclei (PubMed:1374908, PubMed:18708127,
CC       PubMed:7643197, PubMed:8120636). Expressed in globus pallidus (GP)
CC       neurons (PubMed:10414968). {ECO:0000269|PubMed:10414968,
CC       ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:1374908,
CC       ECO:0000269|PubMed:16413129, ECO:0000269|PubMed:18708127,
CC       ECO:0000269|PubMed:1879548, ECO:0000269|PubMed:22831914,
CC       ECO:0000269|PubMed:7643197, ECO:0000269|PubMed:8120636}.
CC   -!- INDUCTION: Up-regulated in visual cortex during the second postnatal
CC       week from dark-reared animals (at protein level). Down-regulated in
CC       visual cortex by active visual experience until postnatal day P40 of
CC       dark-reared animals (PubMed:18708127). Down-regulated by chronic action
CC       potential activity deprivation in organotypic culture of the visual
CC       cortex (PubMed:18775767). {ECO:0000269|PubMed:18708127,
CC       ECO:0000269|PubMed:18775767}.
CC   -!- DOMAIN: The transmembrane segment S4 functions as a voltage-sensor and
CC       is characterized by a series of positively charged amino acids at every
CC       third position. Channel opening and closing is effected by a
CC       conformation change that affects the position and orientation of the
CC       voltage-sensor paddle formed by S3 and S4 within the membrane. A
CC       transmembrane electric field that is positive inside would push the
CC       positively charged S4 segment outwards, thereby opening the pore, while
CC       a field that is negative inside would pull the S4 segment inwards and
CC       close the pore. Changes in the position and orientation of S4 are then
CC       transmitted to the activation gate formed by the inner helix bundle via
CC       the S4-S5 linker region. {ECO:0000250|UniProtKB:P63142}.
CC   -!- PTM: Phosphorylated by PKA in cortical synaptosomes (PubMed:7643197).
CC       cAMP-dependent phosphorylation inhibits channel activity
CC       (PubMed:7643197). Histamine H2 receptor- and PKA-induced
CC       phosphorylation extends action potential spike duration, reduces action
CC       potential spike amplitude, sustains maximum firing frequency in
CC       hippocampal interneurons; also reduces the incidence of high-frequency
CC       oscillations in hippocampal CA3 pyramidal cell layers (By similarity).
CC       {ECO:0000250|UniProtKB:P63142, ECO:0000269|PubMed:7643197}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.2/KCNC2 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M34052; AAA42142.1; -; mRNA.
DR   EMBL; M59211; AAA41819.1; -; mRNA.
DR   EMBL; M59313; AAA41820.1; ALT_SEQ; mRNA.
DR   EMBL; X62839; CAA44643.1; -; mRNA.
DR   EMBL; M84203; AAA42143.1; -; mRNA.
DR   PIR; A39402; A39402.
DR   PIR; B45292; B45292.
DR   PIR; S22703; S22703.
DR   RefSeq; NP_631962.1; NM_139216.1. [P22462-3]
DR   RefSeq; NP_631963.1; NM_139217.1. [P22462-1]
DR   RefSeq; XP_006241389.1; XM_006241327.3. [P22462-1]
DR   RefSeq; XP_017450149.1; XM_017594660.1. [P22462-1]
DR   RefSeq; XP_017450150.1; XM_017594661.1. [P22462-2]
DR   RefSeq; XP_017450152.1; XM_017594663.1.
DR   AlphaFoldDB; P22462; -.
DR   SMR; P22462; -.
DR   BioGRID; 251521; 1.
DR   STRING; 10116.ENSRNOP00000005773; -.
DR   DrugCentral; P22462; -.
DR   GuidetoPHARMACOLOGY; 549; -.
DR   GlyCosmos; P22462; 2 sites, No reported glycans.
DR   GlyGen; P22462; 2 sites.
DR   PhosphoSitePlus; P22462; -.
DR   PaxDb; 10116-ENSRNOP00000005773; -.
DR   ABCD; P22462; 3 sequenced antibodies.
DR   Ensembl; ENSRNOT00000005690.5; ENSRNOP00000005690.2; ENSRNOG00000004077.9. [P22462-3]
DR   Ensembl; ENSRNOT00000005773.8; ENSRNOP00000005773.4; ENSRNOG00000004077.9. [P22462-1]
DR   Ensembl; ENSRNOT00000099049.1; ENSRNOP00000084708.1; ENSRNOG00000004077.9. [P22462-2]
DR   Ensembl; ENSRNOT00000105247.1; ENSRNOP00000088724.1; ENSRNOG00000004077.9. [P22462-4]
DR   Ensembl; ENSRNOT00055020968; ENSRNOP00055016940; ENSRNOG00055012317. [P22462-1]
DR   Ensembl; ENSRNOT00060006183; ENSRNOP00060004592; ENSRNOG00060003730. [P22462-1]
DR   Ensembl; ENSRNOT00065022805; ENSRNOP00065017701; ENSRNOG00065013851. [P22462-1]
DR   GeneID; 246153; -.
DR   KEGG; rno:246153; -.
DR   UCSC; RGD:628829; rat. [P22462-1]
DR   AGR; RGD:628829; -.
DR   CTD; 3747; -.
DR   RGD; 628829; Kcnc2.
DR   eggNOG; KOG3713; Eukaryota.
DR   GeneTree; ENSGT00940000157371; -.
DR   HOGENOM; CLU_011722_4_3_1; -.
DR   InParanoid; P22462; -.
DR   OMA; FYADAMM; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; P22462; -.
DR   TreeFam; TF352511; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   Reactome; R-RNO-381676; Glucagon-like Peptide-1 (GLP1) regulates insulin secretion.
DR   PRO; PR:P22462; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004077; Expressed in frontal cortex and 3 other cell types or tissues.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030673; C:axolemma; IDA:RGD.
DR   GO; GO:0030424; C:axon; IDA:UniProtKB.
DR   GO; GO:0043679; C:axon terminus; IBA:GO_Central.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; IBA:GO_Central.
DR   GO; GO:0098982; C:GABA-ergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IDA:UniProtKB.
DR   GO; GO:0043195; C:terminal bouton; IDA:RGD.
DR   GO; GO:0031982; C:vesicle; IDA:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:UniProtKB.
DR   GO; GO:0099508; F:voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; ISO:RGD.
DR   GO; GO:0071242; P:cellular response to ammonium ion; IEP:RGD.
DR   GO; GO:0071732; P:cellular response to nitric oxide; IDA:UniProtKB.
DR   GO; GO:0097237; P:cellular response to toxic substance; IMP:RGD.
DR   GO; GO:0021759; P:globus pallidus development; IEP:RGD.
DR   GO; GO:0060081; P:membrane hyperpolarization; ISS:UniProtKB.
DR   GO; GO:0034220; P:monoatomic ion transmembrane transport; IDA:RGD.
DR   GO; GO:0038060; P:nitric oxide-cGMP-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0021554; P:optic nerve development; IEP:RGD.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0051291; P:protein heterooligomerization; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0099605; P:regulation of action potential firing rate; ISS:UniProtKB.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0009642; P:response to light intensity; IEP:RGD.
DR   GO; GO:0032026; P:response to magnesium ion; IEP:RGD.
DR   GO; GO:1990089; P:response to nerve growth factor; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   CDD; cd18415; BTB_KCNC2_4; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF172; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY C MEMBER 2; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Postsynaptic cell membrane; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Synapse; Synaptosome;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel; Zinc.
FT   CHAIN           1..638
FT                   /note="Voltage-gated potassium channel KCNC2"
FT                   /id="PRO_0000054054"
FT   TOPO_DOM        1..229
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        230..248
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        284..303
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        304..314
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        315..337
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        346..368
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        369..381
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        382..401
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        451..473
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        474..638
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          47..75
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          538..572
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           437..442
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        56..74
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         124
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         130
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         151
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         152
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         437
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         438
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         439
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         440
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   MOD_RES         564
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14B80"
FT   CARBOHYD        259
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        266
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         594..638
FT                   /note="GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPIPSIL -> AST
FT                   LEPMESTSQTKGDTRPEAHWNCAHLLNFGCPTGSSFPTL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:1879548"
FT                   /id="VSP_001018"
FT   VAR_SEQ         594..638
FT                   /note="GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPIPSIL -> DNC
FT                   KDVVITGYTQAEARSLT (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:2367536"
FT                   /id="VSP_001019"
FT   VAR_SEQ         594..638
FT                   /note="GYEKSRSLNNIAGLAGNALRLSPVTSPYNSPCPLRRSRSPIPSIL -> VLY
FT                   RIYHGFLPAENGTLRFSHSKDCTGNFCY (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:1378392"
FT                   /id="VSP_001020"
FT   MUTAGEN         563
FT                   /note="S->A: Does not abolish channel activity inhibition
FT                   in presence of nitric oxide (NO); when associated with A-
FT                   564. Absence of channel activity inhibition in presence of
FT                   cAMP; when associated with A-564."
FT                   /evidence="ECO:0000269|PubMed:11281123,
FT                   ECO:0000269|PubMed:7643197"
FT   MUTAGEN         564
FT                   /note="S->A: Does not abolish channel activity inhibition
FT                   in presence of nitric oxide (NO); when associated with A-
FT                   564. Absence of channel activity inhibition in presence of
FT                   cAMP; when associated with A-563."
FT                   /evidence="ECO:0000269|PubMed:11281123,
FT                   ECO:0000269|PubMed:7643197"
FT   CONFLICT        2
FT                   /note="G -> S (in Ref. 4; CAA44643)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   638 AA;  70191 MW;  25C102B4CCE53BF4 CRC64;
     MGKIENNERV ILNVGGTRHE TYRSTLKTLP GTRLALLASS EPQGDCLTAA GDKLQPLPPP
     LSPPPRPPPL SPVPSGCFEG GAGNCSSHGG NGSDHPGGGR EFFFDRHPGV FAYVLNYYRT
     GKLHCPADVC GPLFEEELAF WGIDETDVEP CCWMTYRQHR DAEEALDIFE TPDLIGGDPG
     DDEDLGGKRL GIEDAAGLGG PDGKSGRWRK LQPRMWALFE DPYSSRAARF IAFASLFFIL
     VSITTFCLET HEAFNIVKNK TEPVINGTSA VLQYEIETDP ALTYVEGVCV VWFTFEFLVR
     IVFSPNKLEF IKNLLNIIDF VAILPFYLEV GLSGLSSKAA KDVLGFLRVV RFVRILRIFK
     LTRHFVGLRV LGHTLRASTN EFLLLIIFLA LGVLIFATMI YYAERVGAQP NDPSASEHTQ
     FKNIPIGFWW AVVTMTTLGY GDMYPQTWSG MLVGALCALA GVLTIAMPVP VIVNNFGMYY
     SLAMAKQKLP RKRKKHIPPA PLASSPTFCK TELNMACNST QSDTCLGKEN RLLEHNRSVL
     SGDDSTGSEP PLSPPERLPI RRSSTRDKNR RGETCFLLTT GDYTCASDGG IRKGYEKSRS
     LNNIAGLAGN ALRLSPVTSP YNSPCPLRRS RSPIPSIL
//
